Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19368
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Antibodies, Monoclonal/adverse effects/*therapeutic use,Female,Humans,Immunologic Factors/adverse effects/*therapeutic use,Longitudinal Studies,Male,Middle Aged,Patient Compliance,Severity of Illness Index,Spondylitis, Ankylosing/*drug therapy,Treatment Outcome,Tumor Necrosis Factor-alpha/antagonists & inhibitors
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19368
ISSN: 0172-8172
Link: http://www.ncbi.nlm.nih.gov/pubmed/17357804
http://www.springerlink.com/content/y0371043054x66v2/fulltext.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Venetsanopoulou-2007-Persistent clinical.pdf257.96 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons